INFLUENCE OF URSODEOXYCHOLIC ACID TREATMENT ON THE UK-PBC RISK SCORE IN PRIMARY BILIARY CHOLANGITIS

被引：0
|
作者：
Marenco-Flores, Ana
Sierra, Leandro
Kahan, Tamara F.
Barba, Romelia
Ferrigno, Bryan W.
Goyes, Daniela
Medina-Morales, John E.
Bonder, Alan
Patwardhan, Vilas
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1577
引用
收藏
页码：S1699 / S1699
页数：1
相关论文
共 50 条
  • [31] The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
    Kawata, Kazuhito
    Joshita, Satoru
    Shimoda, Shinji
    Yamashita, Yuki
    Yamashita, Maho
    Kitsugi, Kensuke
    Takatori, Shingo
    Ohta, Kazuyoshi
    Ito, Jun
    Shimoyama, Shin
    Noritake, Hidenao
    Suda, Takafumi
    Harada, Kenichi
    HEPATOLOGY RESEARCH, 2021, 51 (01) : 80 - 89
  • [32] Gender and Age at Diagnosis as Factors for Ursodeoxycholic Acid (UDCA) Response in Primary Biliary Cirrhosis (PBC) in the UK-PBC Patient Cohort: a Role for Estrogen as a Disease Co-Factor?
    Pells, Greta
    Mells, George F.
    Newton, Julia L.
    Heneghan, Michael A.
    Neuberger, James
    Day, Darren B.
    Ducker, Samantha J.
    Sandford, Richard N.
    Alexander, Graeme J.
    Jones, David E.
    HEPATOLOGY, 2012, 56 : 1133A - 1133A
  • [33] Ursodeoxycholic acid in patients with primary biliary cholangitis
    Numberger, Markus
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (01):
  • [34] Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy
    Holtmeier, J
    Leuschner, M
    Stiehl, A
    Klein, R
    Leuschner, U
    BILE ACIDS AND PREGNANCY, 2002, 129A : 70 - 74
  • [35] THE IMPACT OF PRIMARY BILIARY CIRRHOSIS (PBC) ON PERCEIVED QUALITY OF LIFE (QoL): THE UK-PBC NATIONAL STUDY
    Mells, G.
    Pells, G.
    Newton, J.
    Bathgate, A.
    Burroughs, A.
    Heneghan, M.
    Neuberger, J.
    Day, D.
    Ducker, S.
    Sandford, R.
    Alexander, G.
    Jones, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S392 - S392
  • [36] Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
    Shu, Yanyun
    Song, Yuhu
    Bai, Tao
    Pan, Xiaoli
    Shang, Haitao
    Yang, Ling
    Ye, Jin
    Du, Fan
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (02) : 187 - 193
  • [37] PREDICTED RISK OF END STAGE LIVER DISEASE UTILIZING THE UK-PBC RISK SCORE IN PBC PATIENTS
    Jones, David
    Carbone, Marco
    Mells, George
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    MacConell, Leigh
    Digpal, Kuldip
    GUT, 2021, 70 : A153 - A154
  • [38] The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210
    Yang, F.
    Yang, Y.
    Wang, Q.
    Wang, Z.
    Miao, Q.
    Xiao, X.
    Wei, Y.
    Bian, Z.
    Sheng, L.
    Chen, X.
    Qiu, D.
    Fang, J.
    Tang, R.
    Gershwin, M. E.
    Ma, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 733 - 743
  • [39] A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
    Yagi, Minami
    Matsumoto, Kosuke
    Komori, Atsumasa
    Abe, Masanori
    Hashimoto, Naoaki
    Inao, Mie
    Namisaki, Tadashi
    Kawata, Kazuhito
    Ninomiya, Masashi
    Fujii, Hideki
    Takahashi, Atsushi
    Kang, Jong-Hon
    Takamura, Masaaki
    Arakawa, Mie
    Joshita, Satoru
    Sato, Ken
    Itakura, Jun
    Nomura, Takako
    Kakisaka, Keisuke
    Kaneko, Akira
    Tamura, Yamato
    Miura, Ryo
    Aiso, Mitsuhiko
    Arizumi, Toshihiko
    Asaoka, Yoshinari
    Kikuchi, Kentaro
    Takikawa, Yasuhiro
    Masaki, Tsutomu
    Umemura, Takeji
    Honda, Akira
    Ohira, Hiromasa
    Kawada, Norifumi
    Yoshiji, Hitoshi
    Mochida, Satoshi
    Takikawa, Hajime
    Tanaka, Atsushi
    LIVER INTERNATIONAL, 2020, 40 (08) : 1926 - 1933
  • [40] DOSING CONSIDERATIONS FOR OBETICHOLIC ACID (OCA) IN THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC).
    Marathe, D.
    Yang, Y.
    Shang, E.
    Li, S.
    Zhao, P.
    Lee, S. -C.
    Mehta, R.
    Omokaro, S. O.
    Dimicksantos, L.
    Davis-Williams, A.
    Meyer, J.
    Egan, A.
    Roman, D.
    Bashaw, E. D.
    Sinha, V.
    Mehrotra, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
12345